Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes

Introduction The aim of this prospective study was to evaluate long-term outcomes in differentiated thyroid cancer (DTC) patients postoperatively treated with distinct RAI activities of 30 mCi, 60 mCi, and 100 mCi. Material and methods The analysis involved 277 low-risk and 46 intermediate-risk pat...

Full description

Bibliographic Details
Main Authors: Aleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska, Ewa Paliczka-Cieslik, Daria Handkiewicz-Junak, Aleksandra Kropińska, Zbigniew Puch, Tomasz Olczyk, Jozef Roskosz, Barbara Jarzab
Format: Article
Language:English
Published: Termedia Publishing House 2020-08-01
Series:Archives of Medical Science
Subjects:
differentiated thyroid cancer
low risk thyroid cancer
radioiodine
remnant ablation
radioiodine treatment
radioiodine activity
Online Access:https://www.archivesofmedicalscience.com/Thyroid-remnant-ablation-with-radioiodine-activity-of-30-60-and-100-mCi-in-patients,110206,0,2.html

Internet

https://www.archivesofmedicalscience.com/Thyroid-remnant-ablation-with-radioiodine-activity-of-30-60-and-100-mCi-in-patients,110206,0,2.html

Similar Items